Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85 (COVIDRASP)
Sponsor: Griffith University
A PHASE3 clinical study on Covid19 and Respiratory Viral Infection, this trial is completed. The trial is conducted by Griffith University and has accumulated 9 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
9 versions recorded-
Jun 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Jun 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Oct 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE3
▶ Show 4 earlier versions
-
May 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE3
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Griffith University
- Princess Alexandra Hospital, Brisbane, Australia
- Queensland Children's Hospital
- Telethon Kids Institute
- The Prince Charles Hospital
- The University of Queensland
For direct contact, visit the study record on ClinicalTrials.gov .